Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, Professor of Medicine at the University of Central Florida, and at Loma Linda University Health, shared a post on LinkedIn:
” GU26 presentations with participation of Adventhealth Cancer Institute, AdventHealth Central Florida, AdventHealth Orlando, Florida-Pleased to coauthor and/or mentor several presentations- collaborations with multiple teams – look for updates and practice-changing or practice-impacting highlights in bladder cancer, prostate cancer, kidney cancer from me as GU26 unfolds late February 2026.”
More posts featuring Guru Sonpavde.
